Skip to main content
. 2021 Jul;32(7):1779–1790. doi: 10.1681/ASN.2020091311

Figure 2.

Figure 2.

Patient flow diagram. In this study, 304 patients were randomized to vadadustat (n=151) or darbepoetin alfa (n=153). Of these, 271 patients completed the 24-week treatment period and 234 patients completed the 52-week treatment period.